# China Biologic Products Holdings, Inc.

China Biologic Products Holdings, Inc. is a company headquartered in Beijing, China.

## Company overview

- **Legal name:** China Biologic Products Holdings, Inc.
- **Former names in filing history:** China Biologic Products, Inc. (2007-09-05 to 2017-07-21)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Beijing, China
- **Fiscal year end:** December 31
- **SEC CIK:** 0001369868

## About

China Biologic Products Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001369868, and its reported industry is Biological Products, (No Diagnostic Substances). In 20-F filed on 2020-03-12, it reported annual revenue of USD 503,744,922; net income of USD 138,807,748; total assets of USD 1,937,858,497 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $503.7M (USD 503,744,922)
- **Net income:** $138.8M (USD 138,807,748)
- **Total assets:** $1.9B (USD 1,937,858,497)
- **Cash and equivalents:** $161.8M (USD 161,750,425)
- **Operating cash flow:** $229.3M (USD 229,342,343)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $466.9M (USD 466,877,569)
- **Net income:** $128.1M (USD 128,056,302)
- **Total assets:** $2.0B (USD 2,009,978,681)
- **Cash and equivalents:** $338.9M (USD 338,880,559)
- **Operating cash flow:** $103.9M (USD 103,941,952)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $370.4M (USD 370,406,840)
- **Net income:** $67.9M (USD 67,943,035)
- **Total assets:** $809.1M (USD 809,057,417)
- **Cash and equivalents:** $219.3M (USD 219,336,848)
- **Operating cash flow:** $102.2M (USD 102,183,885)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $341.2M (USD 341,169,426)
- **Net income:** $104.8M (USD 104,779,307)
- **Total assets:** $605.0M (USD 604,957,509)
- **Cash and equivalents:** $183.8M (USD 183,765,533)

## Recent SEC filings

- Form 6-K — filed 2021-04-20 — period 2021-04-20 — FORM 6-K
- Form 6-K — filed 2021-03-29 — period 2021-03-29 — FORM 6-K
- Form 6-K — filed 2021-03-01 — period 2021-03-01 — FORM 6-K
- Form 6-K — filed 2021-01-25 — period 2021-01-25 — FORM 6-K
- Form SC 13D — filed 2021-01-15 — SCHEDULE 13D
- Form 6-K — filed 2021-01-07 — period 2021-01-07 — FORM 6-K
- Form 6-K — filed 2020-11-24 — period 2020-11-24 — 6-K
- Form 6-K — filed 2020-11-19 — period 2020-11-19 — FORM 6-K
- Form SC 13D — filed 2020-09-23 — SCHEDULE 13D
- Form 6-K — filed 2020-08-17 — period 2020-08-17 — FORM 6-K
- Form 6-K — filed 2020-06-29 — period 2020-06-29 — FORM 6-K
- Form 6-K — filed 2020-05-20 — period 2020-05-20 — 6-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/china-biologic-products-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology